Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients

Abstract

The transmembrane protein-tyrosine phosphatase (PTP) DEP-1 (density-enhanced phosphatase) is a candidate tumor suppressor in the colon epithelium. We have explored the function of DEP-1 in colon epithelial cells by inducible re-expression in a DEP-1-deficient human colon cancer cell line. Density-enhanced phosphatase-1 re-expression led to profound inhibition of cell proliferation and cell migration, and was associated with cytoskeletal rearrangements. These effects were dependent on the PTP activity of DEP-1 as they were not observed with cells expressing the catalytically inactive DEP-1 C1239S variant. shRNA-mediated suppression of DEP-1 in a colon epithelial cell line with high endogenous DEP-1 levels enhanced proliferation, further supporting the antiproliferative function of DEP-1. Nutrients, which are considered to be chemoprotective with respect to colon cancer development, including butyrate, green tea and apple polyphenols, had the capacity to elevate transcription of endogenous DEP-1 mRNA and expression of DEP-1 protein. Upregulation of DEP-1 expression, and in turn inhibition of cell growth and migration may present a previously unrecognized mechanism of chemoprevention by nutrients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Barth SW, Fähndrich C, Bub A, Dietrich H, Watzl B, Will F et al. (2005). Carcinogenesis 26: 1414–1421.

  • Glei M, Matuschek M, Steiner C, Böhm V, Persin C, Pool-Zobel BL . (2003). Toxicol In vitro 17: 723–729.

  • Gosse F, Guyot S, Roussi S, Lobstein A, Fischer B, Seiler N et al. (2005). Carcinogenesis 26: 1291–1295.

  • Iuliano R, Trapasso F, Le Pera I, Schepis F, Sama I, Clodomiro A et al. (2003). Cancer Res 63: 882–886.

  • Jandt E, Denner K, Kovalenko M, Östman A, Böhmer FD . (2003). Oncogene 22: 4175–4185.

  • Kautenburger T, Becker TW, Pool-Zobel BL . (2006). Int J Cancer Prev (in press).

  • Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S . (1996). Cancer Res 56: 4236–4243.

  • Kellie S, Craggs G, Bird IN, Jones GE . (2004). J Cell Sci 117: 609–618.

  • Kovalenko M, Denner K, Sandström J, Persson C, Gross S, Jandt E et al. (2000). J Biol Chem 275: 16219–16226.

  • Lampugnani MG, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F et al. (2003). J Cell Biol 161: 793–804.

  • Le Pera I, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M et al. (2005). Oncogene 24: 3187–3195.

  • Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P et al. (2004). J Biol Chem 279: 29004–29012.

  • Östman A, Yang Q, Tonks NK . (1994). Proc Natl Acad Sci USA 91: 9680–9684.

  • Palka HL, Park M, Tonks NK . (2003). J Biol Chem 278: 5728–5735.

  • Pool-Zobel B, Veeriah S, Böhmer FD . (2005a). Mutat Res 591: 74–92.

  • Pool-Zobel BL, Selvaraju V, Sauer J, Kautenburger T, Kiefer J, Richter KK et al. (2005b). Carcinogenesis 26: 1064–1076.

  • Richter M, Jurek D, Wrba F, Kaserer K, Wurzer G, Karner-Hanusch J et al. (2002). Eur J Cancer 38: 1937–1945.

  • Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, Meijer G et al. (2003). Oncogene 22: 3472–3474.

  • Ruivenkamp CA, Van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T et al. (2002). Nat Genet 31: 295–300.

  • Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB . (2005). Clin Cancer Res 11: 2735–2746.

  • Takahashi T, Takahashi K, St John PL, Fleming PA, Tomemori T, Watanabe T et al. (2003). Mol Cell Biol 23: 1817–1831.

  • Tenev T, Böhmer SA, Kaufmann R, Frese S, Bittorf T, Beckers T et al. (2000). Eur J Cell Biol 79: 261–271.

  • Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P et al. (2000). Mol Cell Biol 20: 9236–9246.

  • Trapasso F, Yendamuri S, Dumon KR, Iuliano R, Cesari R, Feig B et al. (2004). Carcinogenesis 25: 2107–2114.

Download references

Acknowledgements

This work was supported by grants from the German Federal Ministry of Research and Education (BMBF), Grant 01EA0503 (to FDB and BP-Z), and by the Collaborative Research Center of the Deutsche Forschungsgemeinschaft SFB604, Project A1 (to FDB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F D Böhmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balavenkatraman, K., Jandt, E., Friedrich, K. et al. DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 25, 6319–6324 (2006). https://doi.org/10.1038/sj.onc.1209647

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209647

Keywords

This article is cited by

Search

Quick links